Effects of endothelin-1 on arterial and venous resistances in anaesthetized rats

European Journal of Pharmacology

Volumn 327, Issue 2-3, 1997, Pages 183-188

  Palacios, Beatriz ^a   Lim, Su Lin ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arterial resistance; Body; Cardiac output; Circulatory filling pressure; Endothelin 1; Mean; Systemic; Venous resistance; Venous tone

Indexed keywords

ENDOTHELIN 1; PHENTOLAMINE;

ANIMAL EXPERIMENT; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART OUTPUT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE; VASCULAR RESISTANCE; VEIN TONE;

EID: 0030959174     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89659-8     Document Type: Article

References (42)

1. Auguet M., Delaflotte S., Chabrier P.-E., Braquet P. Characterization of endothelin receptors mediating contraction and relaxation in rabbit saphenous artery and vein. Can. J. Physiol. Pharmacol. 71:1993;818-823.
2. Balligand J.L., Godfraind T. Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins. J. Cardiovasc. Pharmacol. 24:1994;618-625.
3. Burnier M., Biollaz J., Brunner D.B., Gavras H., Brunner H.R. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect. J. Pharmacol. Exp. Ther. 224:1983;222-227.
4. Cernacek P., Stewart D.J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem. Biophys. Res. Commun. 161:1989;562-567.
5. Chang H., Wu G.J., Wang S.M., Hung C.R. Plasma endothelin level changes during hemorrhagic shock. J. Trauma. 35:1993;825-833.
6. D'Orléans-Juste P., Claing A., Warner T.D., Yano M., Telemaque S. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br. J. Pharmacol. 110:1993;687-692.
7. A receptor blockade on arterial, venous and capillary functions in skeletal muscle. Acta Physiol. Scand. 148:1993;273-283.
8. Fortes Z.B., De Nucci G., Garcia-Leme J. Effect of endothelin-1 on arterioles and venules in vivo. J. Cardiovasc. Pharmacol. 13(Suppl. 5):1989;S200-S201.
9. Guyton A.C. Determinations of cardiac output by equating venous return curves with cardiac response curves. Physiol. Rev. 35:1955;123-129.
10. Haynes W.G., Clarke J.G., Cockcroft J.R., Webb D.J. Pharmacology of endothelin-1 in vivo in humans. J. Cardiovasc. Pharmacol. 17(Suppl. 7):1991;S284-S286.
11. Haynes W.G., Hand M.F., Johnstone H.A., Padfield P.L., Webb D.J. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. J. Clin. Invest. 94:1994;1359-1364.
12. B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 92:1995;357-363.
13. Lam H.C., Takahashi K., Ghatei M.A., Warrens A.N., Rees A.J., Bloom S.R. Immunoreactive endothelin in human plasma, urine, milk, and saliva. J. Cardiovasc. Pharmacol. 17(Suppl. 7):1991;S390-S393.
14. Lerman A., Hildebrand F.L., Aarhus L.L., Burnett J.C. Endothelin has biological actions at pathophysiological concentrations. Circulation. 83:1991;1808-1814.
15. Lerman A., Hildebrand F.L., Aarhus L.L., Sandok E.K. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation. 85:1992;1894-1898.
16. Maguire J.J., Kuc R.E., O'Reilly G., Davenport A.P. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br. J. Pharmacol. 113:1994;49-54.
17. Morel D.R., Lacroix J.S., Hemsen A., Steinig D.A., Pittet J.-F., Lundberg J.M. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol. 167:1989;427-428.
18. B-like receptors. Biochem. Biophys. Res. Commun. 184:1992;100-106.
19. Opgaard O.S., Adner M., Gulbenkian S., Edvinsson L. Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J. Cardiovasc. Pharmacol. 23:1994;576-583.
20. Pang, C.C.Y., 1994. The Effects of Drugs on the Venous System. Medical Intelligence Unit, R.G. Landes, Austin, TX, pp. 1-139.
21. Pang C.C.Y., Tabrizchi R. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats. Br. J. Pharmacol. 89:1986;389-394.
22. Pernow J., Hemsen A., Lundberg J.M., Nowak J., Kaijser L. Potent vasoconstrictor effects and clearance of endothelin in the human forearm. Acta Physiol. Scand. 141:1991;319-324.
23. Riezebos J., Watts I.S., Vallance P.J.T. Endothelin receptors mediating functional responses in human small arteries and veins. Br. J. Pharmacol. 111:1994;609-615.
24. Rothe C.F. Mean circulatory filling pressure: its meaning and measurements. J. Appl. Physiol. 74:1993;499-509.
25. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
26. Shichiri M., Hirata Y., Ando K., Emori T., Ohta K., Kimoto S., Ogura M., Inoue A., Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 15:1990;493-496.
27. Stewart D.J., Cernacek P., Costello K.B., Rouleau J.L. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 85:1992;510-517.
28. Sugiura M., Inagami T., Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161:1989;1220-1227.
29. Tabrizchi R., Pang C.C.Y. Comparative effects of rauwolscine, prazosin, and phentolamine on blood pressure and cardiac output in anesthetized rats. Can. J. Physiol. Pharmacol. 65:1987;1421-1427.
30. Tabrizchi R., Pang C.C.Y. Effects of drugs on body venous tone, as reflected by mean circulatory filling pressure. Cardiovasc. Res. 26:1992;443-448.
31. Tabrizchi R., Lim S.L., Pang C.C.Y. Possible equilibration of portal venous and central venous pressures during circulatory arrest. Am. J. Physiol. 264:1993;H259-H261.
32. Waeber B., Nussberger J., Brunner H.R. Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats. J. Pharmacol. Exp. Ther. 225:1983;442-446.
33. Waite R.P., Pang C.C.Y. Effects of endothelin on arterial pressure and venous tone in intact and hexamethonium-treated conscious rats. J. Cardiovasc. Pharmacol. 16:1990;940-944.
34. Waite R.P., Pang C.C.Y. The sympathetic nervous system facilitates endothelin-1 effects on venous tone. J. Pharmacol. Exp. Ther. 260:1992;45-50.
35. Waite R.P., Lim S.L., Pang C.C.Y. Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats. Br. J. Pharmacol. 116:1995;2322-2326.
36. G-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats. Br. J. Pharmacol. 114:1995;1454-1458.
37. Warner T.D. Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. Br. J. Pharmacol. 99:1990;427-433.
38. Warrens A.N., Cassidy M.J., Takahashi K., Ghatei M.A., Bloom S.R. Endothelin in renal failure. Nephrol. Dial. Transplant. 5:1990;418-422.
39. B contractile receptors. Eur. J. Pharmacol. 257:1994;307-310.
40. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
41. Yang Z.H., Buhler F.R., Diederich D., Luscher T.F. Different effects of endothelin-1 on cAMP- and cGMP-mediated vascular relaxation in human arteries and veins: comparison with norepinephrine. J. Cardiovasc. Pharmacol. 13(Suppl. 5):1989;S129-S131.
42. Zimmerman R.S., Maymind M., Barbee R.W. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension. 23:1994;205-210.